NASDAQ:CGIX Cancer Genetics Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cancer Genetics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.92 +0.08 (+9.51%) (As of 06/27/2022 12:00 AM ET) Add Compare Share Today's Range$0.84▼$0.9350-Day Range$0.62▼$1.1252-Week Range$2.11▼$17.50Volume220,334 shsAverage Volume2.44 million shsMarket Capitalization$3.76 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsHeadlinesSocial Media View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CGIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cancer Genetics and its competitors with MarketBeat's FREE daily newsletter. Email Address CGIX Stock Forecast (MarketRank)Overall MarketRank™0.00 out of 5 starsHealth Care And Social Assistance Sector1st out of 1 stocksAnalyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cancer Genetics. Previous Next 0.0 Community Rank Outperform VotesCancer Genetics has received 0 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCancer Genetics has received 17 “underperform” votes. (Add your “underperform” vote.)Community SentimentCancer Genetics has received 100.00% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cancer Genetics and other stocks. Vote “Outperform” if you believe CGIX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CGIX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCancer Genetics does not currently pay a dividend.Dividend GrowthCancer Genetics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cancer Genetics insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here About Cancer Genetics (NASDAQ:CGIX)Vyant Bio, Inc. is emerging as an advanced biotechnology drug discovery company. The firm is focused on human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of therapeutics for biopharma partners, as well as for its proprietary pipeline. The company with capabilities in data, science (both biology and chemistry), engineering, and regulatory, it rapidly identifying small and large molecule therapeutics and derisking decision making through multiple in silico, in vitro, and in vivo modalities. It leveraging these modalities, the company is able to capitalize on repurposed and novel compounds and then partner with others to further develop and commercialize valuable therapeutics and new treatments for patients. It operates two wholly-owned subsidiaries, StemoniX and vivoPharm. Vyant Bio was founded in 1999 and is headquartered in Cherry Hill, NJ.Read More CGIX Stock News HeadlinesJune 24, 2022 | msn.com‘Doctor Strange 2’ fans left shocked after discovering Black Bolt’s costume was CGIJune 22, 2022 | americanbankingnews.comCancer Genetics (NASDAQ:CGIX) Research Coverage Started at StockNews.comJune 21, 2022 | apnews.comGoodbody Health launches Genetic Risk Testing for Cancer and Cardiovascular DiseasesJune 21, 2022 | msn.com10 Netflix Movies With The Worst CGI, RankedJune 20, 2022 | finance.yahoo.comNonExomics Unveils Technology to Decode Dark Genome for Diagnosis and Treatment of Diseases Like CancerJune 19, 2022 | msn.comThe Worst Hulk Actor Hates The CGI HulkJune 17, 2022 | msn.comThe Incredible Hulk's Lou Ferrigno Says the MCU's CGI Hero Loses an Important QualityJune 17, 2022 | msn.comOne key Star Wars prequel scene had a fully CGI Anakin and no one realized until nowJune 16, 2022 | americanbankingnews.comStockNews.com Initiates Coverage on Cancer Genetics (NASDAQ:CGIX)June 13, 2022 | msn.comJurassic Park's CGI Tech Was A Test Of Patience For Its StarsJune 7, 2022 | next-generation-communications.tmcnet.comCGI Federal's Momentum® Acquisitions contract writing system goes live at the U.S. Department of Veteran AffairsJune 7, 2022 | seekingalpha.comCGI announces implementation of contract-writing system at U.S. VAJune 6, 2022 | americanbankingnews.comCancer Genetics (NASDAQ:CGIX) Coverage Initiated by Analysts at StockNews.comSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry N/A Sub-IndustryN/A SectorHealth Care and Social Assistance Current SymbolNASDAQ:CGIX CUSIPN/A CIKN/A Webwww.cancergenetics.com Phone(201) 479-1357FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,085,000Free FloatN/AMarket Cap$3.76 million OptionableNot Optionable BetaN/A Cancer Genetics Frequently Asked Questions How has Cancer Genetics' stock performed in 2022? Cancer Genetics' stock was trading at $1.12 at the start of the year. Since then, CGIX shares have decreased by 17.8% and is now trading at $0.9211. View the best growth stocks for 2022 here. Who are Cancer Genetics' key executives? Cancer Genetics' management team includes the following people: John A. Roberts, President, Chief Executive Officer & DirectorAndrew D. C. LaFrence, Chief Operating & Financial OfficerRobert T. Fremeau, Chief Scientific OfficerPing Yeh, Director & Chief Innovation OfficerRalf Brandt, President-Discovery & Early Development Services What is Panna Sharma's approval rating as Cancer Genetics' CEO? 28 employees have rated Cancer Genetics CEO Panna Sharma on Glassdoor.com. Panna Sharma has an approval rating of 37% among Cancer Genetics' employees. This puts Panna Sharma in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Who are some of Cancer Genetics' key competitors? Some companies that are related to Cancer Genetics include Chill Brands Group (CHLL), Alibaba Health Information Technology (ALBHF), APR Energy (APR), Blenheim Natural Resources (BNR), Cosmo Pharmaceuticals (CMOPF), dentalcorp (DNTL.TO), Dialogue Health Technologies (CARE.TO), Entourage Health (ETRGF), IMAC (IMACW), Oxford Nanopore Technologies (ONTTF), SFLMaven (SFLM), Tevano Systems (TEVNF), Unidoc Health (UDOC) and Xebra Brands (XBRAF). View all of CGIX's competitors. What other stocks do shareholders of Cancer Genetics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cancer Genetics investors own include Actinium Pharmaceuticals (ATNM), OPKO Health (OPK), Novavax (NVAX), Sorrento Therapeutics (SRNE), Activision Blizzard (ATVI), Ford Motor (F), Gilead Sciences (GILD), CymaBay Therapeutics (CBAY), Synergy Pharmaceuticals (SGYP) and TherapeuticsMD (TXMD). What is Cancer Genetics' stock symbol? Cancer Genetics trades on the NASDAQ under the ticker symbol "CGIX." How do I buy shares of Cancer Genetics? Shares of CGIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cancer Genetics' stock price today? One share of CGIX stock can currently be purchased for approximately $0.92. How much money does Cancer Genetics make? Cancer Genetics (NASDAQ:CGIX) has a market capitalization of $3.76 million. How can I contact Cancer Genetics? Cancer Genetics' mailing address is 201 State Rt 17 Fl 2, Rutherford, New Jersey 07070-2597. The official website for Cancer Genetics is www.cancergenetics.com. The company can be reached via phone at (201) 479-1357. This page (NASDAQ:CGIX) was last updated on 6/28/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
